| Model Number |
03R89-21 |
| Medical Device Problem Code |
Application Security Problem (2882)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
03/26/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The investigation into this issue found that this vulnerability impacts all marketed versions of aliniq ams and abbottlink.The investigation also identified that the vulnerability can only be exploited on ams-abbottlink systems within customer networks with poor network security (labs with no firewall, or an poorly configured firewall).A product correction letter has been issued to all customers where both abbottlink and aliniq ams are installed.The product correction letter notifies customers of the issue and provides the necessary actions to be taken to reduce the risk of exploitation of this vulnerability until they are contacted by their abbott representative to schedule the mandatory installation of the new version of abbottlink once it is available.
|
| |
|
Event or Problem Description
|
|
The customer reported they were alerted with an error of account blocked in the database.After analysis, it was found that there were 10 attempts to log into the aliniq ams database.The next day there was another block on the oracle user again; an unblock was performed, dain was manually executed and the database was backed up.The running of axeda (abbottlink) on the server was identified, even though it was not connected due to a lack of a valid certificate.Abbottlink was disabled.There was no reported impact to patient management.
|
| |
|
Search Alerts/Recalls
|